New Zealand markets closed

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
57.60-0.21 (-0.36%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5126.53B
Enterprise value 3158.80B
Trailing P/E 93.81
Forward P/E 17.05
PEG ratio (5-yr expected) 113.56
Price/sales (ttm)2.89
Price/book (mrq)3.44
Enterprise value/revenue 33.58
Enterprise value/EBITDA 719.86

Trading information

Stock price history

Beta (5Y monthly) 0.63
52-week change 3-3.47%
S&P500 52-week change 333.64%
52-week high 369.75
52-week low 356.66
50-day moving average 359.89
200-day moving average 364.76

Share statistics

Avg vol (3-month) 39.46M
Avg vol (10-day) 39.2M
Shares outstanding 52.22B
Implied shares outstanding 6N/A
Float 82.19B
% held by insiders 10.07%
% held by institutions 175.33%
Shares short (29 Sep 2021) 419.91M
Short ratio (29 Sep 2021) 41.96
Short % of float (29 Sep 2021) 40.90%
Short % of shares outstanding (29 Sep 2021) 40.90%
Shares short (prior month 30 Aug 2021) 420.32M

Dividends & splits

Forward annual dividend rate 41.96
Forward annual dividend yield 43.40%
Trailing annual dividend rate 31.92
Trailing annual dividend yield 33.32%
5-year average dividend yield 42.91
Payout ratio 4N/A
Dividend date 331 Oct 2021
Ex-dividend date 429 Sep 2021
Last split factor 21000000:951777
Last split date 306 Aug 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin -11.44%
Operating margin (ttm)18.55%

Management effectiveness

Return on assets (ttm)4.31%
Return on equity (ttm)-11.76%

Income statement

Revenue (ttm)44.38B
Revenue per share (ttm)19.78
Quarterly revenue growth (yoy)15.50%
Gross profit (ttm)34.05B
Net income avi to common (ttm)-5.08B
Diluted EPS (ttm)-2.26
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)14.02B
Total cash per share (mrq)6.31
Total debt (mrq)46.29B
Total debt/equity (mrq)125.54
Current ratio (mrq)1.54
Book value per share (mrq)16.56

Cash flow statement

Operating cash flow (ttm)12.51B
Levered free cash flow (ttm)9.86B